Cresco Labs Income Taxes 2020-2025 | CRLBF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Cresco Labs income taxes from 2020 to 2025. Income taxes can be defined as the total amount of income tax expense for the given period.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Cresco Labs income taxes from 2020 to 2025. Income taxes can be defined as the total amount of income tax expense for the given period.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$229.7B
Boston Scientific (BSX)	$152.7B
Stryker (SYK)	$148.7B
EssilorLuxottica (ESLOY)	$131.4B
Medtronic (MDT)	$115.3B
Lonza Group Ag (LZAGY)	$49.7B
Haleon (HLN)	$44.7B
ResMed (RMD)	$37.3B
Agilent Technologies (A)	$35B
GE HealthCare Technologies (GEHC)	$34.4B
Terumo (TRUMY)	$24.6B
Koninklijke Philips (PHG)	$23.1B
Insulet (PODD)	$20.4B
Zimmer Biomet Holdings (ZBH)	$18.6B
Baxter (BAX)	$14.7B
Smith & Nephew SNATS (SNN)	$13.3B
Demant (WILYY)	$9B
Sunny Optical Technology (SNPTF)	$8.6B
Bio-Rad Laboratories (BIO)	$7B
Lantheus Holdings (LNTH)	$5.6B
Perrigo (PRGO)	$3.8B
Prestige Consumer Healthcare (PBH)	$3.8B
Haemonetics (HAE)	$3.6B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.4B
ICU Medical (ICUI)	$3.3B
QuidelOrtho (QDEL)	$2.1B
LeMaitre Vascular (LMAT)	$1.9B
AtriCure (ATRC)	$1.5B
Acuren (TIC)	$1.4B